Press Release 2022 - Sami-Sabinsa Group | Formerly Known as Sami Labs Limited

Sabinsa to Showcase Innovative Hair Care & Skin Care Actives at NYSCC 2022

April 29, 2022

Sabinsa to Highlight Innovative Ingredients in April at Three Trades Shows: in-cosmetics® global - 2022 in France, SAPHEX - 2022 in South Africa and SupplySide® EAST in USA

April 1, 2022

Sami-Sabinsa Introduces CurCousin™ Curcumin Analog Ingredient, Health Benefits Include Supporting Healthy Metabolism and Blood Sugar Levels

February 28, 2022

Sabinsa Secures EFSA Novel Food Approval for C3-Reduct®, the Reduced Metabolites of Curcuminoids

February 17, 2022

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.

Sabinsa to Showcase Innovative Hair Care & Skin Care Actives at NYSCC 2022

Sabinsa to Highlight Innovative Ingredients in April at Three Trades Shows: in-cosmetics® global - 2022 in France, SAPHEX - 2022 in South Africa and SupplySide® EAST in USA

Sami-Sabinsa Introduces CurCousin™ Curcumin Analog Ingredient, Health Benefits Include Supporting Healthy Metabolism and Blood Sugar Levels

Sabinsa Secures EFSA Novel Food Approval for C3-Reduct®, the Reduced Metabolites of Curcuminoids

Certificates

Global Offices

Get in Touch

Disclaimer